Has Theodore Brna received payments from drug or device companies?

Yes. Drug and device makers reported $4,215 in general payments to Theodore Brna across 196 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Theodore Brna did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Theodore Brna come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Theodore Brna

Family Medicine · Bailey, NCNPI 1477547016

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.

$4,215in general payments, 2019–2025

Across 196 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$669
Pfizer$461
GSK$391
Amgen$364
Sanofi-aventis U.S. LLC$318
Teva Pharmaceuticals USA, Inc.$299
plus $2K from 17 others

What the payments were for

Food & beverage$4,207100%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	11	$669
Pfizer	26	$461
GSK	15	$391
Amgen	13	$364
Sanofi-aventis U.S. LLC	11	$318
Teva Pharmaceuticals USA, Inc.	14	$299
Lilly USA, LLC	16	$298
Boehringer Ingelheim	22	$285
Johnson & Johnson	17	$215
Novartis	3	$150
Novo Nordisk	14	$146
Radius Health, Inc.	1	$125
Astellas Pharma US Inc	2	$121
Merck	7	$90
AbbVie(2 entities)	7	$85
Takeda Pharmaceuticals U.S.A., Inc.	7	$73
Eisai Inc.	2	$29
Arbor Pharmaceuticals, Inc.	2	$26
Daiichi Sankyo Inc.	2	$22
Supernus Pharmaceuticals, Inc.	1	$13
Kowa Pharmaceuticals America, Inc.	1	$13
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$11
Ironwood Pharmaceuticals, Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,215 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina →

Other family medicine in Bailey

William CromwellRaleigh$879K
Steve VacalisGastonia$693K
David DundeeWinston Salem$633K
Kevin SodenCharlotte$558K
Brian ForrestApex$398K
Joseph KonenCharlotte$322K
Richard RachimaCharlotte$294K
Dimitrios HondrosCharlotte$275K
Domingo Rodriguez-CueGarner$253K
Christopher ChaoCary$201K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →